Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? (Q33364538)

26 July 2017

1 reference

title

Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies? (English)

1 reference

26 July 2017

Su Golder

1

0 references

Yoon K Loke

series ordinal

2

object named as

Yoon K Loke

1 reference

PubMed ID

18754841

26 July 2017

language of work or name

English

0 references

publication date

31 July 2008

1 reference

British Journal of Clinical Pharmacology

26 July 2017

1 reference

26 July 2017

66

1 reference

26 July 2017

6

1 reference

26 July 2017

767-773

1 reference

Consistency of financial interest disclosures in the biomedical literature: the case of coronary stents

26 July 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Selective Publication of Antidepressant Trials and Its Influence on Apparent Efficacy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Pharmaceutical company funding and its consequences: a qualitative systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Factors associated with findings of published trials of drug-drug comparisons: why some statins appear more efficacious than others

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Methodological shortcomings predicted lower harm estimates in one of two sets of studies of clinical interventions

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Systematic review of publication bias in studies on publication bias

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Better reporting of harms in randomized trials: an extension of the CONSORT statement

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Design and reporting modifications in industry-sponsored comparative psychopharmacology trials

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Third generation oral contraceptives and risk of venous thrombosis: meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Competing interests and controversy about third generation oral contraceptives. BMJ readers should know whose words they read

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Adverse effects of inhaled corticosteroids in funded and nonfunded studies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2675760

A study of manufacturer-supported trials of nonsteroidal anti-inflammatory drugs in the treatment of arthritis

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18754841

12 December 2020

inferred from PubMed ID database lookup

Conflict of interest in the debate over calcium-channel antagonists

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18754841

12 December 2020

inferred from PubMed ID database lookup

The uncertainty principle and industry-sponsored research

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/18754841

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1111/J.1365-2125.2008.03272.X

1 reference

release_j4uezebjsvhs7gaef2wtxrqf7u

26 July 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/j4uezebjsvhs7gaef2wtxrqf7u

24 November 2022

mapped directly with Wikidata item

PMCID

2675760

1 reference

26 July 2017

1 reference

PubMed ID

18754841